Navigation Links
Sorrento Therapeutics Receives Frost & Sullivan's Prestigious 2013 Global Investment Opportunity Award in the Oncology Market
Date:6/6/2013

tential bioequivalence (BE) to Abraxane® to get Cynviloq™ to the market quickly and at minimal cost using the FDA 505(b)(2) BE application pathway that allows companies to obtain FDA approval of new drug applications (NDAs) for reformulations of drugs with the same active ingredient.

"Sorrento is unique in its ability to potentially have an approved oncology product within the next few years using an abbreviated 505(b)(2) BE pathway at a fraction of the cost of what is spent by traditional drug development companies," noted Frost & Sullivan Industry Analyst Justin Collishaw . "Our independent analysis confirms that other competitors lack similar near-term approvable therapies, which may be able to generate revenues in the next three to four years."

Sorrento, through its IGDRASOL acquisition, also secured EU distribution rights, which give Sorrento the flexibility to form alliances with multinational companies seeking late-stage drug products to fill in gaps in their pipeline. In addition, Sorrento is moving forward in the field of true personalized medicine with the development of Therapeutic Drug Monitoring (TDM), which will complement and expand the Cynviloq™ franchise in the market.

Sorrento's next strength lies in its outstanding management team that boasts an impressive track record of long-term vision and timely execution. Such an industry-leading management team will help Sorrento's valuable products reach their full potential.

"Partnership with large pharma could accelerate Sorrento's development program and broaden its portfolio into inflammation and infectious diseases," noted Collishaw. "As a publicly traded company, Sorrento has the added advantage of access to the public investment market."

Sorrento is further consolidating its market position by targeting therapeutic areas with an unmet need. The company is selecting antibody candidates that have strong
'/>"/>

SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Sorrento Therapeutics Awarded Third Phase I STTR Grant
2. Sorrento Therapeutics Signs Exclusive Option to Acquire IGDRASOL
3. Sorrento Therapeutics, Inc. and IGDRASOL Announce Presentation on Non-Biologic Nanoparticle paclitaxel (NBN-Pac) Formulations for the Treatment of Solid Tumors at the Nanomedicine 2013 Meeting in Barcelona, Spain
4. Sorrento Therapeutics, Inc. announces its approach to developing human antibody therapeutics against MRSA receives continued support from the National Institute of Allergy and Infectious Diseases
5. Sorrento Therapeutics to Present at the Jefferies 2013 Global Healthcare Conference in New York City
6. Sorrento Therapeutics Receives Frost & Sullivans 2013 Global Investment Opportunity Award in Oncology
7. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
8. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
9. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
10. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
11. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... -- On July 31, the Food and Drug Administration sent ... forward to regulate laboratory-developed tests (LDTs). The clock is ... U.S. will need to comply with a host of ... subscribe to the strategy to simply sit back and ... it,s widely acknowledged that failure to answer key questions ...
(Date:9/2/2014)... Sept. 2, 2014 Reportlinker.com announces that a ... Asia - Pacific Minimally Invasive Surgery ... The growth rate of the ... will remain at double-digit levels throughout the forecast period. ... future of this field. The Asia-Pacific ...
(Date:9/2/2014)... NEW YORK , Sept. 2, 2014 /PRNewswire/ ... report is available in its catalogue: ... 2020 http://www.reportlinker.com/p02343483/BRIC-Bariatric-Surgery-Devices-Market-Outlook-to-2020.html ... 2020 Summary GlobalData,s ... to 2020", provides key market data on the ...
Breaking Medicine Technology:FDA Tells Congress It Intends to Regulate LDTs! Web Conference to Provide Straight Talk on Essential Steps Clinical Laboratories and Pathology Groups Will Need to Take to Comply 2FDA Tells Congress It Intends to Regulate LDTs! Web Conference to Provide Straight Talk on Essential Steps Clinical Laboratories and Pathology Groups Will Need to Take to Comply 3Asia - Pacific Minimally Invasive Surgery Spinal Device Market 2Asia - Pacific Minimally Invasive Surgery Spinal Device Market 3Asia - Pacific Minimally Invasive Surgery Spinal Device Market 4Asia - Pacific Minimally Invasive Surgery Spinal Device Market 5Asia - Pacific Minimally Invasive Surgery Spinal Device Market 6Asia - Pacific Minimally Invasive Surgery Spinal Device Market 7Asia - Pacific Minimally Invasive Surgery Spinal Device Market 8Asia - Pacific Minimally Invasive Surgery Spinal Device Market 9Asia - Pacific Minimally Invasive Surgery Spinal Device Market 10BRIC Bariatric Surgery Devices Market Outlook to 2020 2BRIC Bariatric Surgery Devices Market Outlook to 2020 3BRIC Bariatric Surgery Devices Market Outlook to 2020 4BRIC Bariatric Surgery Devices Market Outlook to 2020 5BRIC Bariatric Surgery Devices Market Outlook to 2020 6BRIC Bariatric Surgery Devices Market Outlook to 2020 7BRIC Bariatric Surgery Devices Market Outlook to 2020 8BRIC Bariatric Surgery Devices Market Outlook to 2020 9BRIC Bariatric Surgery Devices Market Outlook to 2020 10
... Technologies Corp. (NASDAQ: BSTC ), a biopharmaceutical ... XIAFLEX® in the U.S. and XIAPEX® in Eurasia, today ... the upcoming Lazard Capital Markets 8th Annual Healthcare Conference ... New York, NY.   The live webcast ...
... Nov. 9, 2011 GenVec, Inc. (Nasdaq: GNVC ) ... 30, 2011.   GenVec reported a net loss of ... 30, 2011 compared to a net loss of $2.4 million ($0.18 ... months ended September 30, 2011, GenVec,s net loss was $4.9 million ...
Cached Medicine Technology:BioSpecifics Technologies Corp. to Present at Lazard Capital Markets 8th Annual Healthcare Conference 2GenVec Reports Third Quarter 2011 Financial Results 2GenVec Reports Third Quarter 2011 Financial Results 3GenVec Reports Third Quarter 2011 Financial Results 4GenVec Reports Third Quarter 2011 Financial Results 5
(Date:9/2/2014)... Recently, iFitDress.com, a famous online supplier of ... its range of 2014 seashell wedding dresses . ... prices. A large proportion of them are priced under ... are carefully made by the most skilled workers. Along ... gowns, ivory satin wedding gowns, white halter wedding gowns, ...
(Date:9/2/2014)... 02, 2014 TCG, a leading government technology ... as one of the fastest-growing companies in America for the ... TCG was previously recognized in 2013, 2012, 2011, 2010, 2009, ... has grown 86% from 2010 to 2013, ranking the company ... businesses in America - up 635 spots from 2013! More ...
(Date:9/2/2014)... Angeles, CA (PRWEB) September 02, 2014 ... article on its website titled “Why You Should Wash ... than 80 percent of the global population breathes air ... and particles of pollution lodge in the skin’s pores ... body’s natural barrier to free radicals that may cause ...
(Date:9/2/2014)... cancer cells can lay the groundwork for their own ... vessels to send out tumor-welcoming signals, according to a ... the Sept. 2 issue of Nature Communications , ... increased levels of so-called signaling molecules released by breast ... in the lungs and lymph nodes to produce proteins ...
(Date:9/2/2014)... Kathleen Doheny HealthDay Reporter ... U.S. obesity epidemic is a driving force behind the rising ... Researchers looked at data from five national surveys spanning ... in diabetes over time could be explained by factors such ... adults. The investigators found that the prevalence of diabetes ...
Breaking Medicine News(10 mins):Health News:Discounted Seashell Wedding Dresses Currently Provided By iFitDress.com 2Health News:TCG One of the Fastest-Growing Companies in America – for the Eighth Time! 2Health News:Simon Ourian, Kim Kardashian’s Doctor: Air Pollution May Be Aging Your Skin 2Health News:‘Prepped’ by tumor cells, lymphatic cells encourage breast cancer cells to spread 2Health News:Obesity Fueling Rise in Diabetes Rates, Study Finds 2Health News:Obesity Fueling Rise in Diabetes Rates, Study Finds 3
... Pharmaceuticals, Inc.,("Rib-X" or the "Company"), a development-stage company ... for the treatment of,antibiotic-resistant infections, announced today that ... scheduled to present at the,Rodman & Renshaw 10th ... 2:00pm EST. The conference will be held from ...
... lead has eroded since previous poll, Democratic contender,still ... 3 In the waning days of the,2008 ... (D-Ill.) over Sen. John McCain (R-Ariz.) by a ... MedPage Today, LLC, (http://www.MedPageToday.com )., (Photo: ...
... for further study, ITHACA, N.Y., Nov. 3 ... & Adolescent Medicine has published a new,study by ... trigger for autism among genetically vulnerable children. It,is ... prevalence of,autism to a factor related to the ...
... research, experts say , , MONDAY, Nov. 3 (HealthDay News) ... from mouse bodies that had been frozen for up ... the specter of resurrecting lost species a la ... recreating woolly mammoths was "probably impossible." , He ...
... Despite ongoing efforts to educate the public about HIV, ... Corp., Harvard University and Children,s Hospital Boston has found ... fears about spreading HIV in the home. , The ... members, including minor children, in families with an HIV-infected ...
... conclude that a review which claimed that homeopathy is just ... flawed. , George Lewith, Professor of Health Research ... which trials were analysed nor of the various vital assumptions ... If we presume that homeopathy works for some conditions but ...
Cached Medicine News:Health News:Rib-X Pharmaceuticals, Inc. to Present at the Rodman & Renshaw 10th Annual Healthcare Conference 2Health News:Election-Eve MedPage Today(R) Poll Gives Obama Double-Digit Lead Among Clinicians 2Health News:Election-Eve MedPage Today(R) Poll Gives Obama Double-Digit Lead Among Clinicians 3Health News:AMA Journal Publishes Study Showing Evidence of a Major Environmental Trigger For Autism 2Health News:AMA Journal Publishes Study Showing Evidence of a Major Environmental Trigger For Autism 3Health News:Scientists Make Clones of Mice Dead 16 Years 2Health News:Study finds fears of HIV transmission in families with infected parent 2Health News:New evidence for homeopathy 2
... Basic ergonomic chairs with ... with lumbar support • Select ... and casters and glides. • ... the following environments: industry, education, ...
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTT/1P chairs are recommended for ... clean room, static control, health care ...
... Durable ergonomic chairs with concave seats ... • Select options like seats, backrests, ... Choose the BE Series for top ... including: industry, education, laboratory, clean room, ...
... with concave seats and large backrests ... like seats, backrests, armrests, and casters ... Series for top performance in a ... laboratory, clean room, static control, health ...
Medicine Products: